Department of Nephrology, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, China.
Department of Nephrology, Wuhan Hospital of Traditional Chinese and Western Medicine, Wuhan, China.
Ren Fail. 2023 Dec;45(1):2188088. doi: 10.1080/0886022X.2023.2188088.
To explore the predictive value of the proportion of glomerulosclerosis (GS) incidences on the progression of membranous nephropathy with non-nephrotic proteinuria (NNP).
This study was a single-center, retrospective, cohort study. Patients with biopsy-proven idiopathic membranous nephropathy were divided into three groups based on the proportion of glomerular sclerosis, and their demographic, clinical, and pathological data were compared. The proportions of primary and secondary endpoints were recorded, and the relationship between GS and primary outcomes (progression to nephrotic syndrome, complete remission, and persistent NNP) and the renal composite endpoint was analyzed.
A total of 112 patients were divided into three groups according to the proportions of glomerulosclerosis. The median follow-up time was 26.5 (13-51) months. There were significant differences in blood pressure ( < 0.01), renal interstitial lesions ( < 0.0001), and primary endpoints ( = 0.005). The survival analysis showed that prognosis was significantly worse in patients with a high proportion of GS than in those patients with a middle and low proportion of GS ( < 0.001). The Cox multivariate analysis showed that after adjusting for age, sex, BP, 24-h urinary protein, serum creatinine, treatment scheme, and pathological factors, the risk of renal composite outcome in the low proportion group was 0.076 times higher than that in the high proportion group ( = 0.009, HR = 0.076, 95% CI: 0.011-0.532).
A high level of glomerulosclerosis was an independent risk factor for the prognosis of patients with membranous nephropathy with non-nephrotic proteinuria.
探讨肾小球硬化比例(GS)对非肾病性蛋白尿膜性肾病(NNP)进展的预测价值。
本研究为单中心回顾性队列研究。根据肾小球硬化比例,将经活检证实的特发性膜性肾病患者分为三组,比较其人口统计学、临床和病理资料。记录主要和次要终点的比例,并分析 GS 与主要终点(进展为肾病综合征、完全缓解和持续 NNP)和肾脏复合终点的关系。
根据肾小球硬化比例,共 112 例患者分为三组。中位随访时间为 26.5(13-51)个月。三组间血压( < 0.01)、肾间质病变( < 0.0001)和主要终点( = 0.005)差异有统计学意义。生存分析显示,GS 比例高的患者预后明显差于 GS 比例中、低的患者( < 0.001)。Cox 多因素分析显示,在校正年龄、性别、BP、24 h 尿蛋白、血清肌酐、治疗方案和病理因素后,低比例组发生肾脏复合结局的风险是高比例组的 0.076 倍( = 0.009,HR = 0.076,95%CI:0.011-0.532)。
肾小球硬化程度高是膜性肾病非肾病性蛋白尿患者预后的独立危险因素。